General Motors looks forward to joining hands with M&M for servicing all its vehicles
Category: #world  By Dhananjay Punekar  Date: 2017-06-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

General Motors looks forward to joining hands with M&M for servicing all its vehicles

General Motors, the global automotive market player had recently announced its plan to quit the Indian market. To achieve the same, the company intends to enter into a strategic alliance with Mahindra & Mahindra, an established behemoth across the automotive sector in the Indian sub-continent.

As per authentic reports, GM has been trying to wind up its stock across the country. Clearing up the entire stock and pulling out of the business altogether is no mean task, say experts, owing to which GM planned to carve out a service and dealership business with top automotive giants. A high-grade official of General Motors was quoted saying that the company is looking out for a percentage based dealership with India’s most popular companies operating in the automotive sector, with the top ones being Mahindra & Mahindra and Maruti Suzuki.

General Motors’ strategy of establishing a service and dealership business with their automotive competitors will prove to be profitable for the organization over the years ahead, as per industry experts. The ground level approach of Mahindra & Mahindra and Maruti Suzuki in this case, is to play the role of fund raiser. This business tactic is slated to attract more customers, owing to the extensive availability of dealership and service centers in the country.

For clearing the stocks of the vehicles such as Chevrolet Cruze, Chevrolet Beat, and Trailblazer SUV, General Motors has made the aforementioned products available at a huge discounted price for the customers. As per a legal news snippet, GM is offering discounts ranging from INR 1 lakh to INR 4 lakh on specific vehicle segment. Under this strategic agreement, M&M is also expected to provide workshop services to GM vehicles. This alliance is likely to prove beneficial to Mahindra and Mahindra, as GM will be paying royalty for such services.

Apart from the vehicle sales, GM is continuing its research and manufacturing work in specific locations across the nation. General Motors is also looking forward to collecting more revenue via exports through India. GM has also shut down the automotive production plant in Halol in April 2017.

This move by GM is likely to generate lucrative avenues for the Indian automotive giants to dominate the regional business space. The dealership programs of GM have been attracting major industry players. Maruti Suzuki is also on board to favor this alliance, and is predicted to double the number of Nexa network outlets by 2020.



About Author

Dhananjay Punekar

Email: [email protected]   

Dhananjay Punekar

Dhananjay Punekar presently develops content for a slew of portals, including Market Size Forecasters and Algosonline. A post graduate in mathematics and business administration, he worked in Infosys BPO Limited prior to switching his professional genre. As a content wr...

Read More

More News By Dhananjay Punekar

AstraZeneca gets import & marketing approval for Durvalumab in India
AstraZeneca gets import & marketing approval for Durvalumab in India
By Dhananjay Punekar

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from the Indian drug regulating agency DCGI (Drug Controller General of India) for its drug Durvalumab c...

BP exits deal with Woolworths, retail firm looks out for alternatives
BP exits deal with Woolworths, retail firm looks out for alternatives
By Dhananjay Punekar

BP Plc, a UK based oil & gas firm, has decided to terminate its USD 1.8 billion acquisition deal with Australian retail giant Woolworths. For the record, the British oil & gas company had signed a pact to purch...

Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
By Dhananjay Punekar

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the firm released initial results derived from clinical treatment on patients suffering from Duchenne mus...